Related Experiment Video
Updated: May 26, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
HIV point-of-care testing pitfalls.
1The Courtyard Clinic, St Georges Hospital, London, UK. sumyeeyorkies@yahoo.co.uk
International Journal of STD & AIDS
|December 17, 2011
Summary
Post-exposure prophylaxis (PEP) efficacy may be low if risks occurred before treatment. Current HIV tests can miss early infection during the
Area of Science:
- Infectious Diseases
- Virology
- Public Health
Background:
- Post-exposure prophylaxis (PEP) is crucial after potential sexual exposure to prevent Human Immunodeficiency Virus (HIV) infection.
- Timely initiation of PEP, ideally within 72 hours, is recommended to maximize its effectiveness.
Observation:
- The efficacy of PEP can be compromised by pre-existing risks or factors occurring before the 72-hour window for treatment initiation.
- Even with a combination of advanced diagnostic methods, including point-of-care tests, fourth-generation HIV assays, and HIV RNA detection, early HIV infection can remain undetected.
Findings:
- Current diagnostic strategies may fail to identify seroconversion during the 'eclipse' phase, the earliest period of infection before antibodies or detectable viral load.
- The limitations of these tests in detecting the very initial stages of HIV infection highlight potential gaps in early diagnosis.
Implications:
- Healthcare providers must counsel patients on the potential limitations of PEP efficacy, especially when risk factors predate the treatment window.
- Further research is needed to develop more sensitive diagnostic tools capable of detecting HIV infection during the earliest, 'eclipse' phase to improve patient management and outcomes.
